NIPT Results Interpreter

No — and this is the single most important thing to understand about it. NIPT (also called cfDNA screening) is a screening test: it estimates the chance that a pregnancy is affected by certain chromosome conditions by analyzing placental DNA fragments circulating in the pregnant person's blood. It is remarkably good screening, but it remains a probability, not an answer. A 'low risk' result greatly lowers the odds without proving the baby is unaffected, and a 'high risk' or 'positive' result raises the odds without proving the baby is affected. Only a diagnostic test — chorionic villus sampling (CVS) or amniocentesis, which examine the fetus's actual chromosomes — can confirm or rule out a condition. ACOG and SMFM are explicit that no irreversible decision should ever be made on an NIPT result alone.

Positive predictive value (PPV) is the chance that a positive screen is truly correct — that a baby flagged as 'high risk' actually has the condition. It is NOT the same as the test's accuracy (sensitivity/specificity), and it swings dramatically with two things: which condition, and your prior (background) risk. Because these conditions are rare, even a very accurate test produces false positives. For Down syndrome, PPV is high in older pregnant people (where the condition is more common) and meaningfully lower in younger ones — the same 'positive' can mean a large majority chance in one person and closer to a coin-flip or less in another. For rarer findings — trisomy 13, sex-chromosome conditions, and especially microdeletions like 22q11.2 — PPV is substantially lower across the board, sometimes well under half, because the conditions are rarer still. That's why a positive result is a reason to get counseling and a diagnostic test, not a verdict. Ask specifically for the PPV calculated for your result and your situation; a genetic counselor can produce it.

It's genuinely reassuring, but 'low risk' is not a guarantee, for three reasons. First, screening has a residual false-negative rate — rarely, an affected pregnancy screens low. Second, NIPT only looks for the specific conditions on the panel that was ordered (commonly trisomies 21, 18, 13, and sometimes sex chromosomes or a few microdeletions); it does not screen for the hundreds of other genetic and structural conditions, single-gene disorders, or birth defects a baby could have. Third, a normal cfDNA result does not replace the detailed anatomy ultrasound (usually around 18–22 weeks), which looks for physical differences the DNA screen can't see. So 'low risk' rightly lowers your worry about the screened conditions while leaving the rest of routine prenatal care exactly as it was. Enjoy the reassurance; keep your appointments.

It means the lab couldn't return a reliable result, most often because the fetal fraction (the share of the DNA sample that came from the placenta) was too low to analyze. Common, usually benign reasons include testing too early in pregnancy (fetal fraction rises with gestational age), a higher body weight (which dilutes the fetal fraction), and simple lab or timing variation. A repeat draw a week or two later succeeds in many cases. However, a persistent no-call is also weakly associated with a higher chance of certain aneuploidies, so guidelines treat it as a reason for a careful conversation, not just an automatic redraw — your clinician may offer genetic counseling, a detailed ultrasound, or diagnostic testing depending on your situation. It is not itself a positive result, and it is not a reason to panic; it is a reason to follow up rather than assume everything's fine or everything's wrong.

Two things, in this order, and before any decision that can't be undone. First, genetic counseling: a genetic counselor or maternal-fetal medicine specialist can calculate the real positive predictive value for your specific result and situation, explain what the condition would mean, and lay out your options without pressure. Second, diagnostic testing: CVS (from about 10–13 weeks) or amniocentesis (from about 15 weeks) examines the fetus's own chromosomes and gives a yes-or-no answer, converting a probability into a fact. A detailed ultrasound is often done alongside but does not by itself confirm or exclude a chromosome condition. Take the time these steps require; a screening result creates urgency in feeling but not in fact, and rushing an irreversible choice on a probability is exactly what the whole screening framework is designed to prevent. Bring the actual lab report to your appointments — the specific condition, the reported risk, and the fetal fraction all matter.

Yes. This tool runs entirely in your browser: your answers are evaluated on your own device and are never sent to a server, saved, or shared — close the tab and they're gone. There's no account and no tracking. What you get back is general educational information based on ACOG, SMFM, and MedlinePlus guidance on cfDNA screening; it is not a diagnosis, not a calculation of your personal risk number, and not a substitute for the genetic counseling and diagnostic testing that a real result deserves. Its one job is to help you understand what your result is — and isn't — before those conversations.